Qube Research & Technologies (QRT)
VINC

Qube Research & Technologies (QRT)’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio VINC Stock Details VINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Hold
0
– -$4 – 4307
2024
Q2 		– Sell
-124
Closed -$3.11K – 3669
2024
Q1 		$12.5K Buy
+124
New +$7.84K ﹤0.01% 3769
2023
Q4 		– Hold
0
– – – 4211
2023
Q3 		– Hold
0
– – – 3981
2022
Q4 		– Sell
-744
Closed -$21K – 3096
2022
Q3 		$21K Sell
744
-122
-14% -$3.51K ﹤0.01% 2293
2022
Q2 		$23K Buy
+866
New +$38.5K ﹤0.01% 2252

Other funds holding VINC

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SRC
Sage Rhino Capital Menlo Park, California $535M AUM 24.07% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT)'s VINC Position: Q3 2024 in Review

Qube Research & Technologies (QRT) held its Vincerx Pharma, Inc. Common Stock (VINC) position steady in Q3 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4307.

Qube Research & Technologies (QRT) first reported a position in VINC in Q2 2022 and has held it in 3 quarters since. The position peaked at $23K in Q2 2022. 28 funds tracked by Wall St. Rank hold VINC as of Q3 2024.

  • Qube Research & Technologies (QRT) held 0 shares of Vincerx Pharma, Inc. Common Stock worth $0 as of Q3 2024.
  • Qube Research & Technologies (QRT) left its Vincerx Pharma, Inc. Common Stock share count unchanged in Q3 2024.
  • Vincerx Pharma, Inc. Common Stock made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2024, its #4307 holding.
  • Qube Research & Technologies (QRT) first reported a position in Vincerx Pharma, Inc. Common Stock in Q2 2022 and has held it in 3 quarters since.
  • Qube Research & Technologies (QRT)'s Vincerx Pharma, Inc. Common Stock position peaked at $23K in Q2 2022.
  • 28 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.